Publicacións (26) Publicacións de Gustavo Fernández Pajarín

2024

  1. Talamotomía unilateral con ultrasonidos focales de alta intensidad en pacientes con temblor esencial refractario: un estudio comparativo entre pacientes menores y mayores de 70 años

    Revista de neurologia, Vol. 78, Núm. 12, pp. 335-341

2023

  1. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  2. Estimulación cerebral profunda subtalámica en un caso de enfermedad de Parkinson idiopática y esquizofrenia

    Revista de neurologia, Vol. 77, Núm. 7, pp. 167-170

  3. Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson's disease

    Neurologia, Vol. 38, Núm. 5, pp. 350-356

2022

  1. Apomorfina y disfunción frontal en la enfermedad de Parkinson

    Revista de neurologia, Vol. 74, Núm. 11, pp. 367-371

  2. Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson's disease: A prospective study of 22 patients

    Clinical Parkinsonism and Related Disorders, Vol. 6

  3. Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

    Brain Sciences, Vol. 12, Núm. 3

  4. Parkinson’s Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation

    Diagnostics, Vol. 12, Núm. 4

2021

  1. Continuous Subcutaneous Apomorphine Infusion before Subthalamic Deep Brain Stimulation: A Prospective, Comparative Study in 20 Patients

    Movement Disorders Clinical Practice, Vol. 8, Núm. 8, pp. 1216-1224

  2. Invalidating Hyoid Dystonia: Successful Treatment with IncobotulintoxinA

    Movement Disorders Clinical Practice, Vol. 8, Núm. 2, pp. 264-266

2020

  1. Intolerance to dopaminergic medication and deep brain stimulation: A report of 3 cases

    Neurologia

  2. Parkinson's disease secondary to 2 mutations of genes involved in lysosomal protein degradation

    Neurologia

2019

  1. Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation

    Journal of Neurology, Vol. 266, Núm. 3, pp. 659-666

  2. Polirradiculoneuropatía desmielinizante inflamatoria crónica asociada al tratamiento con infusión intraduodenal de levodopa-carbidopa

    Revista de Neurologia

2018

  1. Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson’s disease

    Revista de Neurologia, Vol. 67, Núm. 1, pp. 1-5

2017

  1. Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients

    Journal of Neurology, Vol. 264, Núm. 5, pp. 946-954

  2. Delayed complications of deep brain stimulation: 16-year experience in 249 patients

    Acta Neurochirurgica, Vol. 159, Núm. 9, pp. 1713-1719

2016

  1. Bilateral pallidal deep brain stimulation in myoclonus-dystonia: our experience in three cases and their follow-up

    Acta Neurochirurgica, Vol. 158, Núm. 10, pp. 2023-2028

  2. Deep brain bilateral pallidal stimulation in chorea-acanthocytosis caused by a homozygous VPS13A mutation

    European Journal of Neurology

  3. Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson's Disease: The APO-NIGHT Study

    Journal of Parkinson's Disease, Vol. 6, Núm. 4, pp. 787-792